1,062 Shares in ICU Medical, Inc. (NASDAQ:ICUI) Acquired by SG Americas Securities LLC

SG Americas Securities LLC bought a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) in the 4th quarter, HoldingsChannel reports. The firm bought 1,062 shares of the medical instruments supplier’s stock, valued at approximately $106,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Covestor Ltd increased its stake in ICU Medical by 86.4% in the first quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 57 shares during the last quarter. Private Trust Co. NA grew its position in shares of ICU Medical by 1,428.6% in the 3rd quarter. Private Trust Co. NA now owns 321 shares of the medical instruments supplier’s stock worth $38,000 after buying an additional 300 shares during the last quarter. Lazard Asset Management LLC purchased a new position in shares of ICU Medical during the third quarter valued at approximately $68,000. Point72 Hong Kong Ltd bought a new position in shares of ICU Medical during the first quarter valued at approximately $94,000. Finally, Group One Trading L.P. boosted its holdings in ICU Medical by 54.6% in the first quarter. Group One Trading L.P. now owns 566 shares of the medical instruments supplier’s stock valued at $126,000 after acquiring an additional 200 shares in the last quarter. Institutional investors own 96.10% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, KeyCorp lifted their target price on shares of ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research note on Wednesday, February 28th. One analyst has rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $123.00.

Insiders Place Their Bets

In other news, VP Daniel Woolson sold 791 shares of ICU Medical stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares in the company, valued at $1,373,814.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director George A. Lopez sold 1,890 shares of the company’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $104.22, for a total value of $196,975.80. Following the transaction, the director now owns 317,753 shares in the company, valued at approximately $33,116,217.66. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Daniel Woolson sold 791 shares of the firm’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the sale, the vice president now owns 13,980 shares of the company’s stock, valued at $1,373,814.60. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 24,262 shares of company stock worth $2,545,532. 6.70% of the stock is currently owned by company insiders.

ICU Medical Price Performance

Shares of ICUI stock opened at $95.77 on Friday. The business’s fifty day moving average is $102.30 and its 200 day moving average is $98.62. The company has a quick ratio of 1.06, a current ratio of 2.53 and a debt-to-equity ratio of 0.74. The stock has a market cap of $2.33 billion, a price-to-earnings ratio of -77.86 and a beta of 0.69. ICU Medical, Inc. has a twelve month low of $78.28 and a twelve month high of $212.43.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. The firm had revenue of $587.86 million for the quarter, compared to the consensus estimate of $564.77 million. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. Research analysts expect that ICU Medical, Inc. will post 3.52 EPS for the current fiscal year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.